Ecovaleric Inc.

An electrochemical manufacturing company developing scalable production of biomass-derived chemicals and materials.

The University of Colorado Connection

is an electrochemical manufacturing company developing scalable production of biomass-derived chemicals and materials. Its first commercial product is gamma-valerolactone (GVL), a bio-based, high-performance solvent and chemical intermediate that could replace hazardous solvents in advanced manufacturing applications.

Ecovaleric was founded in 2024 through the Embark Deep Tech Startup Creator at CU Âé¶¹Ó°Ôº, part of Venture Partners. Co-founder and CEO Ìýjoined the program to commercialize technology developed by , associate professor of chemical and biological engineering at CU Âé¶¹Ó°Ôº and fellow in the Renewable and Sustainable Energy Institute (RASEI), and , then a researcher in chemical and biological engineering at CU Âé¶¹Ó°Ôº.

Funding Status and Investment Opportunities

  • Industry Applications: Advanced Materials, Environment and Sustainability, Cleantech, Manufacturing, Chemicals
  • Funding Round: Pre-Seed
  • Contact for Investment Inquiries: , roberta@ecovaleric.com

Technology Development Funding

U.S. National Science Foundation, National Renewable Energy Laboratory

U.S. National Science Foundaiton (NSF), National Renewable Energy Laboratory (NREL)


ÌýÌý ÌýThis page was last updated on July 31, 2027. Please email vpnews@colorado.edu for corrections or updates

The Insider Investor Newsletter

The InsiderÌýisÌýVenture Partners at CU Âé¶¹Ó°Ôº's monthly newsletter featuring theÌýlatest headlines, news, events, opportunities and emerging innovations from the university. We have several editions for our audiences.

Subscribe to The InsiderÌýÌý

Questions Âé¶¹Ó°Ôº Investment Opportunities?

Amy Dodenhoff

Amy Dodenhoff · Director of Venture Development

Contact AmyÌý

Media Inquiries

For marketing inquiries and news tips, contact Daniel Leonard,Ìýsenior marketing and communications specialist for Venture Partners at CU Âé¶¹Ó°Ôº.

For media inquiries, please visit .